Conning Inc. Danaher Corp Transaction History

Conning Inc.

$2.67 Billion
Q4 2024

A detailed history of Conning Inc. transactions in Danaher Corp stock. As of the latest transaction made, Conning Inc. holds 24,277 shares of DHR stock, worth $5.02 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares

24,277

Previous 21,259 14.2%

Holding current value

$5.02 Million

Previous $5.91 Million 5.7%

% of portfolio

0.21%

Previous 0.2%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 28, 2025	BUY	$226.16 - $274.52 $682,550 - $828,501	3,018 Added 14.2%	24,277 $5.57 Million
Q3 2024 Oct 29, 2024	BUY	$239.25 - $280.76 $87,565 - $102,758	366 Added 1.75%	21,259 $5.91 Million
Q2 2024 Jul 26, 2024	SELL	$235.51 - $267.98 $479,733 - $545,875	-2,037 Reduced 8.88%	20,893 $5.22 Million
Q1 2024 Apr 26, 2024	BUY	$224.58 - $256.19 $65,577 - $74,807	292 Added 1.29%	22,930 $5.73 Million
Q4 2023 Jan 29, 2024	BUY	$185.1 - $233.13 $603,426 - $760,003	3,260 Added 16.82%	22,638 $5.24 Million
Q3 2023 Oct 26, 2023	SELL	$233.08 - $265.59 $327,477 - $373,153	-1,405 Reduced 6.76%	19,378 $4.81 Million
Q2 2023 Jul 21, 2023	SELL	$224.99 - $256.14 $172,342 - $196,203	-766 Reduced 3.55%	20,783 $4.99 Million
Q1 2023 Apr 27, 2023	BUY	$239.75 - $277.0 $3.75 Million - $4.34 Million	15,655 Added 265.61%	21,549 $5.43 Million
Q4 2022 Feb 07, 2023	SELL	$241.42 - $282.29 $11,346 - $13,267	-47 Reduced 0.79%	5,894 $1.56 Million
Q3 2022 Oct 28, 2022	SELL	$247.06 - $1507.4 $97,094 - $592,408	-393 Reduced 6.2%	5,941 $1.54 Million
Q2 2022 Jul 20, 2022	SELL	$237.11 - $299.66 $6,876 - $8,690	-29 Reduced 0.46%	6,334 $1.61 Million
Q1 2022 May 02, 2022	BUY	$257.27 - $315.76 $9,776 - $11,998	38 Added 0.6%	6,363 $1.87 Million
Q4 2021 Jan 27, 2022	SELL	$292.08 - $329.01 $946,047 - $1.07 Million	-3,239 Reduced 33.87%	6,325 $2.08 Million
Q3 2021 Nov 05, 2021	BUY	$272.21 - $332.43 $503,588 - $614,995	1,850 Added 23.98%	9,564 $2.91 Million
Q2 2021 Jul 29, 2021	SELL	$225.08 - $271.69 $216,301 - $261,094	-961 Reduced 11.08%	7,714 $2.07 Million
Q1 2021 Apr 23, 2021	SELL	$212.38 - $245.9 $157,161 - $181,966	-740 Reduced 7.86%	8,675 $1.95 Million
Q4 2020 Jan 28, 2021	SELL	$212.5 - $245.46 $65,662 - $75,847	-309 Reduced 3.18%	9,415 $2.09 Million
Q3 2020 Oct 21, 2020	BUY	$177.16 - $215.33 $28,345 - $34,452	160 Added 1.67%	9,724 $2.09 Million
Q2 2020 Aug 07, 2020	SELL	$128.7 - $176.83 $55,340 - $76,036	-430 Reduced 4.3%	9,564 $1.69 Million
Q1 2020 Apr 29, 2020	SELL	$121.39 - $169.05 $7,162 - $9,973	-59 Reduced 0.59%	9,994 $1.38 Million
Q4 2019 Jan 29, 2020	SELL	$133.47 - $153.48 $51,919 - $59,703	-389 Reduced 3.73%	10,053 $1.54 Million
Q3 2019 Oct 30, 2019	BUY	$135.4 - $146.47 $2,843 - $3,075	21 Added 0.2%	10,442 $1.51 Million
Q2 2019 Jul 25, 2019	SELL	$124.88 - $143.73 $4.47 Million - $5.15 Million	-35,798 Reduced 77.45%	10,421 $1.49 Million
Q1 2019 Apr 22, 2019	SELL	$97.62 - $132.29 $851,246 - $1.15 Million	-8,720 Reduced 15.87%	46,219 $6.1 Million
Q4 2018 Jan 29, 2019	SELL	$94.85 - $109.54 $196,813 - $227,295	-2,075 Reduced 3.64%	54,939 $5.67 Million
Q3 2018 Oct 26, 2018	SELL	$98.13 - $108.9 $66,630 - $73,943	-679 Reduced 1.18%	57,014 $6.2 Million
Q2 2018 Jul 25, 2018	SELL	$96.1 - $103.24 $60,543 - $65,041	-630 Reduced 1.08%	57,693 $5.69 Million
Q1 2018 May 04, 2018	SELL	$92.16 - $103.8 $5,529 - $6,228	-60 Reduced 0.1%	58,323 $5.71 Million
Q4 2017 Jan 30, 2018	SELL	$85.26 - $94.62 $12,789 - $14,193	-150 Reduced 0.26%	58,383 $5.42 Million
Q3 2017 Oct 20, 2017	BUY	$79.29 - $88.45 $4.64 Million - $5.18 Million	58,533	58,533 $5.02 Million

Others Institutions Holding DHR

# of Institutions

2,488

Shares Held

545M

Call Options Held

7.08M

Put Options Held

4.48M

View Full List

About DANAHER CORP

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $151B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

More about DHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Conning Inc., based on Form 13F filings with the SEC.

News

Stay updated on Conning Inc. with notifications on news.

Account